ArticlePLoS computational biology2026
Alignment-free prediction of cross-reactivity in influenza A (H3N2) anticipates antigenic drift.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Since its introduction in 1968, Influenza A (H3N2) has undergone continuous antigenic evolution, necessitating frequent vaccine updates. To predict antigenicity and characterize antigenic drift without multiple sequence alignments, we present FluEmbed, a computational framework that leverages protein language models. FluEmbed accurately quantified the antigenic impact of viral evolution from RNA sequences, achieving strong predictive performance against hemagglutination inhibition (HI) assay titers (Spearman correlation: ρ = 0.67-0.80). FluEmbed also outperformed sequence-distance baselines (e.g., Hamming and BLOSUM62) and phylogenetic tree-based models that require sequence alignment. Using this model, we conducted in-silico mutagenesis experiments to identify site/amino acid combinations that differentially impacted antigenicity. To systematically investigate how specific mutations influence immune escape, we defined two classes of mutations: 'constrained', where only the most likely amino acid changes at historically mutation-prone sites were considered (thereby limiting the mutation space) and 'unconstrained', where all possible substitutions were allowed, providing a full exploration of potential antigenic shifts. Constrained mutations often confer limited antigenic changes, whereas unconstrained mutations exhibit greater escape potential, particularly outside the dominant viral lineages. Notably, 3C.2a was the only major lineage in which constrained and unconstrained mutations showed no significant difference (p ≈ 0.95), suggesting ongoing intra-clade competition rather than inter-lineage antigenic replacement. By enabling rapid, alignment-free antigenic prediction directly from sequence data, FluEmbed could complement traditional HI assays in real-time influenza surveillance and inform vaccine strain selection decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.